Spider (ATH:SPID)

Back to SPID
Kraig Biocraft Laboratories' Monster Silkworms Pleased the Crowds at 2012 Techtextil North America

LANSING, Mich., May 1, 2012 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB.PK) (the "Company") announces that the Company exhibited its Monster Silk™ technology at the recently concluded Techtextil North America conference in Atlanta, Georgia. The Company's exhibit, which featured living transgenic silkworms, Monster Silk™ cocoons, spools of recombinant spider silk and the Company's CEO, was the first exhibition of recombinant spider silk technology to the greater technical textile community. The Company used the event as a mass networking venue to promote its Monster Silk(TM) technology to textile industry experts, corporations and governmental professionals.

"In most cases we were introducing technical textile companies to our spider silk technology," said CEO Kim K Thompson. "But many attendees had been following our development of Monster Silk™ and sought us out when they learned we would be exhibiting.

"Techtextil North America exceeded our expectations and goals in terms of the overwhelmingly positive response we received from industry representatives," continued Thompson. "Numerous attendees expressed outright amazement at our recombinant spider silk technology."

"One of our key conference objectives was to meet with representatives of a number of specific companies who we had long targeted as potential Monster Silk™ commercialization partners. The Techtextil conference actually exceeded our expectations in that regard as well, as we were able to meet with most of those companies, along with representatives of a great many other companies in the technical textile industry. We're most pleased with these initial meetings and with the reception that the conference attendees gave our recombinant spider silk. Of course we are only looking for a very limited number of companies to act as commercialization partners for recombinant spider silk based products. We want to thank the Techtextil organizers as well as all of the conference attendees who made our debut a resounding success."

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (http://www.KraigLabs.com) is a fully reporting biotechnology company that has achieved a series of scientific breakthroughs with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "develops," "researching," "research," "potential," "could" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company's financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

CONTACT: Ben Hansel
         Hansel Capital
         (720) 288-8495
Back to SPID
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki